Pure Global

Study of the Impact of Frequency of Changing PICCline Dressings in Patients With Acute Leukemia - Trial NCT05793801

Access comprehensive clinical trial information for NCT05793801 through Pure Global AI's free database. This phase not specified trial is sponsored by Centre Hospitalier Universitaire de Nฤซmes and is currently Recruiting. The study focuses on Leukemia. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05793801
Recruiting
other
Trial Details
ClinicalTrials.gov โ€ข NCT05793801
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Study of the Impact of Frequency of Changing PICCline Dressings in Patients With Acute Leukemia

Study Focus

Leukemia

Dressing change

Interventional

other

Sponsor & Location

Centre Hospitalier Universitaire de Nฤซmes

Montpellier, France

Timeline & Enrollment

N/A

Jun 06, 2023

Sep 01, 2024

60 participants

Primary Outcome

Rate of local and/or systemic occurrence of infection on the PICCline in controls,Rate of local and/or systemic occurrence of infection on the PICCline in controls,Rate of local and/or systemic occurrence of infection on the PICCline in controls,Rate of local and/or systemic occurrence of infection on the PICCline in controls,Rate of local and/or systemic occurrence of infection on the PICCline in controls,Rate of local and/or systemic occurrence of infection on the PICCline in controls,Rate of local and/or systemic occurrence of infection on the PICCline in controls,Rate of local and/or systemic occurrence of infection on the PICCline in controls,Rate of local and/or systemic occurrence of infection on the PICCline in controls,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group

Summary

Peripherally Inserted Central Catheters have been widely used for many years for the
 administration of chemotherapy to patients with cancer. However, its use entails significant
 infectious complications and high risks of death.The hypothesis is that increasing the rate
 of PICCline dressing changes will reduce the occurrence of catheter-related infections.

ICD-10 Classifications

Leukaemia, unspecified
Myeloid leukaemia
Myeloid leukaemia, unspecified
Other myeloid leukaemia
Monocytic leukaemia, unspecified

Data Source

ClinicalTrials.gov

NCT05793801

Non-Device Trial